Meridian Bioscience increases fiscal '05 EPS, rev views

CarolynPritchard

SAN FRANCISCO (MarketWatch) -- Meridian Biosciences Inc.
VIVO, -1.09%
on Monday increased its fiscal 2005 earnings and revenue forecasts. The life sciences company said that it now expects to report a per-share profit of 73 cents to 76 cents for the year, vs. its previous expectation of 66 cents to 70 cents. The new forecast assumes an increase in average shares outstanding to 16.1 million from 15.3 million at fiscal 2004 year-end. Cincinnati-based Meridian also said that, due to stronger-than-expected third-quarter shipments, it now sees 2005 revenue coming in at $89 million to $92 million compared with a prior forecast of $84 million to $88 million.

Intraday Data provided by SIX Financial Information and subject to terms of use.
Historical and current end-of-day data provided by SIX Financial Information.
All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only.
Intraday data delayed at least 15 minutes or per exchange requirements.